Retailers, suppliers to convene for the 2011 NACDS Pharmacy & Technology Conference
ALEXANDRIA, Va. — The National Association of Chain Drug Stores is gearing up for this year’s Pharmacy & Technology Conference in Boston in late August, an event that will bring together more than 130 retail companies representing more than 80,000 retail outlets.
This year’s conference will take place Aug. 27 to 30 at the Boston Convention & Exhibition Center.
The conference will bring together more than 130 retail companies comprised of chain drug stores, supermarkets and mass merchants, representing more than 80,000 retail outlets and more than $200 billion in annual sales for prescription drugs, OTC products and home health care.
The conference features business and educational programming, speakers and opportunities for retailers and suppliers to do business. The program includes:
- Meet the Retailer, which is designed specifically for first-time attendees from small and mid-sized associate member companies, and will offer multiple 45-minute sessions with senior retail executives from retailers companies. Participants include Rite Aid, H-E-B, Chain Drug Consortium, Supervalu and Walgreens;
- Meet the Rx Market, which will pair retailers and suppliers for personalized appointments to discuss products and services;
- Daily business programs, which offer attendees the opportunity to hear from industry experts and keynote speakers on a variety of issues that impact day-to-day business. Speakers include Robert Loeffler, chief administrative officer of H-E-B and NACDS chairman; Steve Anderson, president and CEO of NACDS; Debbie Garza, divisional VP government and community relations for Walgreens and NACDS Pharmacy & Technology Conference chair; Michael Leavitt, former secretary of Health and Human Services and current chairman of Leavitt Partners; Douglas Long, VP industry relations at IMS Health; and Harry Totonis, president and CEO of SureScripts; and
- Attendees also will be able to obtain continuing education credits from 22 education sessions throughout the four-day conference.
Political pundit Karl Rove to speak at CRN conference
WASHINGTON — The Council for Responsible Nutrition earlier this week announced that political pundit and former White House senior adviser Karl Rove will be a featured speaker at The Conference, CRN’s annual symposium for the dietary supplement industry.
Speaking on the final day of The Conference, Rove will provide his thoughts on the current political climate and share his insight into the inner workings of Congress, the White House and the political process. He also will share some personal recollections from his nearly eight years as a close adviser to President George W. Bush and from his extensive career in American politics.
“Karl Rove is one of the premiere political strategists of the last half-century," stated John Venardos, chair of The Conference and SVP worldwide regulatory, government and industry affairs for Herbalife. "[Rove] has had a front-row seat to many important moments in American history and was actively involved in several of the most hotly contested political campaigns of the last 30 years. His time spent in the White House as deputy chief of staff and senior adviser to President Bush makes him a living witness to history, and his speech will surely be one of the highlights of The Conference.”
The Conference takes place Oct. 19 to 22 at the Terranea Resort in Rancho Palos Verdes, Calif.
Amylin, Takeda discontinue development of obesity drug
SAN DIEGO — Amylin Pharmaceuticals and Takeda Pharmaceutical have halted development of a treatment for obesity in mid-stage clinical trials, the two companies said.
The companies said the decision to discontinue development of a therapy that combines pramlintide and metreleptin was based on "a commercial reassessment of the pramlintide/metreleptin program … [that] took into account a revised development plan, as well as evolving dynamics within he obesity therapeutic area."
Nevertheless, the companies said they would continue investigating other treatments for obesity.